AIM To review all cases of B3 lesion diagnosed at initial image-guided needle biopsy over
two 5-year cohorts to identify upgrade rates to malignancy and the effect of changing …

In the setting of breast cancer screening, 5–9% of needle core biopsies are diagnosed as
lesions of uncertain malignant potential (B3). The management of these lesions is potentially …

Purpose Breast lesions classified as of “uncertain malignant potential” represent a
heterogeneous group of abnormalities with an increased risk of associated malignancy …

Purpose We retrospectively investigated clinical, radiological, and pathological features of
B3 lesions associated with the risk of subsequent upgrade to malignancy. Methods: We …

Purpose To investigate clinical, radiologic and pathologic features of B3 lesions diagnosed
on VABB targeting microcalcifications, for identifying predictors of malignancy. Method This …

Percutaneous needle biopsy plays a crucial role in deciding the management of suspicious
breast findings, both in the clinical and screening setting. The evolution from fine needle …

Background Core needle biopsy (CNB) is a standard diagnostic procedure in the setting of
breast cancer screening. However, CNB may result in the borderline diagnoses of lesion of …

Purpose To investigate a risk stratification strategy for lesions of uncertain malignant
potential (B3) diagnosed by vacuum-assisted breast biopsy (VABB) of mammographic …

Simple Summary Image-guided biopsy of suspicious findings at mammography or breast
ultrasonography can result in the diagnosis of lesions with uncertain malignant potential (B3 …

Introduction Lesions of uncertain malignant potential (B3) represent 10% of core needle
biopsies (CNBs) or vacuum-assisted breast biopsies (VABBs). Traditionally, B3 lesions are …